These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14622362)

  • 21. Toxicity profile of dual methotrexate combinations with gold, hydroxychloroquine, sulphasalazine and minocycline in rheumatoid arthritis patients.
    Elkayam O; Yaron M; Zhukovsky G; Segal R; Caspi D
    Rheumatol Int; 1997; 17(2):49-53. PubMed ID: 9266620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of intramuscular gold and sulphasalazine in the treatment of early rheumatoid arthritis. A one year prospective study.
    Peltomaa R; Paimela L; Helve T; Leirisalo-Repo M
    Scand J Rheumatol; 1995; 24(6):330-5. PubMed ID: 8610215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment.
    Bevis PJ; Bird HA; Lapham G
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():56-60. PubMed ID: 8630639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of meloxicam in patients with rheumatoid arthritis.
    Lemmel EM; Bolten W; Burgos-Vargas R; Platt P; Nissilä M; Sahlberg D; Björneboe O; Baumgartner H; Valat JP; Franchimont P; Bluhmki E; Hanft G; Distel M
    J Rheumatol; 1997 Feb; 24(2):282-90. PubMed ID: 9034984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigations on analgesic, anti-inflammatory and ulcerogenic potential of meloxicam solid dispersion prepared with skimmed milk.
    Mishra DN; Vijaya Kumar SG
    Yakugaku Zasshi; 2006 Jul; 126(7):495-8. PubMed ID: 16819271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy with sulphasalazine and azathioprine.
    Helliwell PS
    Br J Rheumatol; 1996 May; 35(5):493-4. PubMed ID: 8646444
    [No Abstract]   [Full Text] [Related]  

  • 27. Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study.
    Capell HA; Madhok R; Porter DR; Munro RA; McInnes IB; Hunter JA; Steven M; Zoma A; Morrison E; Sambrook M; Wui Poon F; Hampson R; McDonald F; Tierney A; Henderson N; Ford I
    Ann Rheum Dis; 2007 Feb; 66(2):235-41. PubMed ID: 16926184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulphasalazine-induced systemic lupus erythematosus in a patient with rheumatoid arthritis.
    Khattak FH; Morris IM; Mattingly PC
    Br J Rheumatol; 1996 Jan; 35(1):104. PubMed ID: 8624617
    [No Abstract]   [Full Text] [Related]  

  • 29. Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration.
    Euller-Ziegler L; Vélicitat P; Bluhmki E; Türck D; Scheuerer S; Combe B
    Inflamm Res; 2001 Mar; 50 Suppl 1():S5-9. PubMed ID: 11339521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Side effect profile of 200 patients with inflammatory arthritides treated with sulphasalazine.
    Farr M; Scott DG; Bacon PA
    Drugs; 1986; 32 Suppl 1():49-53. PubMed ID: 2877853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COMPARISON OF PRE-EMPTIVE EFFECT OF MELOXICAM AND CELECOXCIB ON POST-OPERATIVE ANALGESIA: A DOUBLE-BLIND, RANDOMIZED CLINICAL TRIAL.
    Aghadavoudi O; Saryazdi HH; Shafa A; Ramezani A
    Middle East J Anaesthesiol; 2015 Oct; 23(3):289-94. PubMed ID: 26860018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DRESS syndrome induced by sulphasalazine in rheumatoid arthritis.
    Bejia I; Ben Hammouda S; Riahi K; Zinelabidine F; Mediouni B; Touzi M; Bergaoui N
    Joint Bone Spine; 2006 Dec; 73(6):764-5. PubMed ID: 16626997
    [No Abstract]   [Full Text] [Related]  

  • 33. The Chinese herbal remedy Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis.
    Ann Intern Med; 2009 Aug; 151(4):I-36. PubMed ID: 19687475
    [No Abstract]   [Full Text] [Related]  

  • 34. Population pharmacokinetic analysis of meloxicam in rheumatoid arthritis patients.
    Meineke I; Türck D
    Br J Clin Pharmacol; 2003 Jan; 55(1):32-8. PubMed ID: 12534638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of pharmacokinetic interaction of meloxicam with methotrexate in patients with rheumatoid arthritis.
    Hübner G; Sander O; Degner FL; Türck D; Rau R
    J Rheumatol; 1997 May; 24(5):845-51. PubMed ID: 9150070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease.
    Borg AA
    Br J Rheumatol; 1995 Nov; 34(11):1097-8. PubMed ID: 8542218
    [No Abstract]   [Full Text] [Related]  

  • 38. Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis.
    Quallich LG; Greenson J; Haftel HM; Fontana RJ
    BMC Gastroenterol; 2001; 1():8. PubMed ID: 11570976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Powdered self-emulsified lipid formulations of meloxicam as solid dosage forms for oral administration.
    Agarwal V; Alayoubi A; Siddiqui A; Nazzal S
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1681-9. PubMed ID: 23072611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rheumatoid arthritis: progress in diagnosis and treatment. Topics: IV. Treatment; 2. Antirheumatic agents, 1) non-biologic agents].
    Tamura N
    Nihon Naika Gakkai Zasshi; 2012 Oct; 101(10):2873-9. PubMed ID: 23214096
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.